These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35419643)

  • 1. The prognostic significance of biomarkers in cerebrospinal fluid following severe traumatic brain injury: a systematic review and meta-analysis.
    Hvingelby VS; Bjarkam CR; Mathiesen TI; Poulsen FR; Bøtker MT; Husted A; Korshoej AR
    Neurosurg Rev; 2022 Aug; 45(4):2547-2564. PubMed ID: 35419643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum biomarkers as predictors of long-term outcome in severe traumatic brain injury: analysis from a randomized placebo-controlled Phase II clinical trial.
    Raheja A; Sinha S; Samson N; Bhoi S; Subramanian A; Sharma P; Sharma BS
    J Neurosurg; 2016 Sep; 125(3):631-41. PubMed ID: 26722854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injury.
    Nwachuku EL; Puccio AM; Adeboye A; Chang YF; Kim J; Okonkwo DO
    Clin Neurol Neurosurg; 2016 Oct; 149():1-5. PubMed ID: 27450760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine Responses in Severe Traumatic Brain Injury: Where There Is Smoke, Is There Fire?
    Casault C; Al Sultan AS; Banoei M; Couillard P; Kramer A; Winston BW
    Neurocrit Care; 2019 Feb; 30(1):22-32. PubMed ID: 29569129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury.
    Santarsieri M; Kumar RG; Kochanek PM; Berga S; Wagner AK
    Brain Behav Immun; 2015 Mar; 45():15-27. PubMed ID: 25218898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain injury biomarkers as outcome predictors in pediatric severe traumatic brain injury.
    Daoud H; Alharfi I; Alhelali I; Charyk Stewart T; Qasem H; Fraser DD
    Neurocrit Care; 2014 Jun; 20(3):427-35. PubMed ID: 23943317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 as a prognostic biomarker of clinical outcomes after traumatic brain injury: a systematic review.
    Ooi SZY; Spencer RJ; Hodgson M; Mehta S; Phillips NL; Preest G; Manivannan S; Wise MP; Galea J; Zaben M
    Neurosurg Rev; 2022 Oct; 45(5):3035-3054. PubMed ID: 35790656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Markers of Macrophage and Lymphocyte Activation After Traumatic Brain Injury in Children.
    Newell E; Shellington DK; Simon DW; Bell MJ; Kochanek PM; Feldman K; Bayir H; Aneja RK; Carcillo JA; Clark RS
    Pediatr Crit Care Med; 2015 Jul; 16(6):549-57. PubMed ID: 25850867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated cerebrospinal fluid galectin-3 and associated cytokines after severe traumatic brain injury in patients.
    Yip PK; Leung WS; Cetin MA; Chang TW; Yeap MC; Chen CT; Wang YC; Chen CC; Liu ZH
    Medicine (Baltimore); 2024 Aug; 103(31):e38620. PubMed ID: 39093775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Biomarkers in severe traumatic brain injury: enhancing prognostic accuracy and therapeutic strategies".
    Nadeem M; Shahzad UB; Ahmed M; Khan MAF
    Neurosurg Rev; 2024 Sep; 47(1):608. PubMed ID: 39271500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal Fluid and Microdialysis Cytokines in Severe Traumatic Brain Injury: A Scoping Systematic Review.
    Zeiler FA; Thelin EP; Czosnyka M; Hutchinson PJ; Menon DK; Helmy A
    Front Neurol; 2017; 8():331. PubMed ID: 28740480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on, "Interleukin-6 as a prognostic biomarker of clinical outcomes after traumatic brain injury: a systematic review".
    Chellapandian H; Jeyachandran S
    Neurosurg Rev; 2024 Sep; 47(1):614. PubMed ID: 39271528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.
    Hayakata T; Shiozaki T; Tasaki O; Ikegawa H; Inoue Y; Toshiyuki F; Hosotubo H; Kieko F; Yamashita T; Tanaka H; Shimazu T; Sugimoto H
    Shock; 2004 Aug; 22(2):102-7. PubMed ID: 15257081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine Blood Tests for Severe Traumatic Brain Injury: Can They Predict Outcomes?
    Dolmans RGF; Hulsbergen AFC; Gormley WB; Broekman MLD
    World Neurosurg; 2020 Apr; 136():e60-e67. PubMed ID: 31655234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor expression correlates with severity and outcome of traumatic brain injury in children.
    Chiaretti A; Antonelli A; Riccardi R; Genovese O; Pezzotti P; Di Rocco C; Tortorolo L; Piedimonte G
    Eur J Paediatr Neurol; 2008 May; 12(3):195-204. PubMed ID: 17881264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofluid Biomarkers in Traumatic Brain Injury: A Systematic Scoping Review.
    Edalatfar M; Piri SM; Mehrabinejad MM; Mousavi MS; Meknatkhah S; Fattahi MR; Kavyani Z; Hajighadery A; Kaveh M; Aryannejad A; Ghafouri M; Jamshidi E; Rezwanifar MM; Sadeghi-Naini M; Bari A; Sharif-Alhoseini M
    Neurocrit Care; 2021 Oct; 35(2):559-572. PubMed ID: 33403583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury.
    Shiozaki T; Hayakata T; Tasaki O; Hosotubo H; Fuijita K; Mouri T; Tajima G; Kajino K; Nakae H; Tanaka H; Shimazu T; Sugimoto H
    Shock; 2005 May; 23(5):406-10. PubMed ID: 15834305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after severe traumatic brain injury: a systematic literature review.
    Mostert CQB; Singh RD; Gerritsen M; Kompanje EJO; Ribbers GM; Peul WC; van Dijck JTJM
    Acta Neurochir (Wien); 2022 Mar; 164(3):599-613. PubMed ID: 35098352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Glial Fibrillary Acidic Protein in Patients With Moderate and Severe Traumatic Brain Injury: A Systematic Review and Meta-Analysis.
    Shemilt M; Boutin A; Lauzier F; Zarychanski R; Moore L; McIntyre LA; Nadeau L; Fergusson DA; Mercier E; Archambault P; Lamontagne F; Perron C; Léger C; Turgeon AF
    Crit Care Med; 2019 Jun; 47(6):e522-e529. PubMed ID: 30889029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum S100A12 as a prognostic biomarker of severe traumatic brain injury.
    Feng MJ; Ning WB; Wang W; Lv ZH; Liu XB; Zhu Y; Gao W; Jin HZ; Gao SS
    Clin Chim Acta; 2018 May; 480():84-91. PubMed ID: 29408171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.